We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Sunesis Pharmaceuticals, Inc. today announced that it has earned a $4.25 million payment from Merck & Co., Inc. for meeting certain
preclinical milestones in the companies' collaboration to develop oral small molecule inhibitors of beta-amyloid converting enzyme (BACE), which is believed to play a key role in Alzheimer's disease.
The medical diagnostics division of German pharmaceutical conglomerate Bayer AG is planning a $100 million expansion of its East Walpole facility growth that will add at least 70 jobs to the 700 the company already employs here.
Medivir is presenting an R&D update this afternoon on oral herpes project Lipsovir (ME 609) and the company's protease-based projects on Hepatitis C, osteoporosis and COPD (Chronic Obstructive Pulmonary Disease).
German chemical and pharmaceutical company Bayer AG Friday bought shares of rival Schering AG on the market in response to Merck KGaA reaching a 10.1% stake in Schering.
The FDA's Center for Drug Evaluation and Research recommends in a new guidance that developers of antiviral drugs and biological
products conduct nonclinical studies on a range of subjects before starting a Phase I clinical trial.
Following the recommendations of a report just released by its Counterfeit Task Force, the FDA has decided to allow pedigree requirements for prescription drugs to go into effect in December because pharmaceutical manufacturers have failed to adopt the
electronic track-and-trace technology on the scale the agency urged them to implement by 2007.
A&G Pharmaceutical and South Korean biopharmaceutical company Celltrion have entered into an agreement for clinical production of A&G's theranostic monoclonal antibody for the treatment of cancer.